_Alexey_Kotelnikov_Alamy.jpg?width=1280&auto=webp&quality=80&disable=upscale#)
FDA’s Conditional Approval Plan Would Unleash Biotech Innovation
In a move that could dramatically reshape the landscape for rare disease treatments, FDA Commissioner Marty Makary announced plans for conditional approval pathways
In a move that could dramatically reshape the landscape for rare disease treatments, FDA Commissioner Marty Makary announced plans for conditional approval pathways
